Archive for August, 2007
Next Entries »Clinical Depression Linked To Abnormal Emotional Brain Circuits
Wednesday, August 15th, 2007In what may be the first study to use brain imaging to look at the neural circuits involved in emotional control in patients with depression, researchers at the University of Wisconsin-Madison have found that brains of people with clinical depression react very differently than those of healthy people when trying to cope with negative situations. [click link for full article]
Study Of Brain Blood Flow May Lead To Improved Depression Treatment
Sunday, August 12th, 2007The usefulness of established molecular imaging/nuclear medicine approaches in identifying the ‘hows’ and ‘whys’ of brain dysfunction and its potential in providing immediately useful information in treating depression are emphasized in a study in the August Journal of Nuclear Medicine. [click link for full article]
Spanish Study Links Depression And Genetic, Environmental Factors
Saturday, August 11th, 2007In spite of the fact that the causes of depression have still not been fully identified, scientists acknowledge that genetic and environmental factors play a common role in the onset of this disorder. One of the environmental risk factors more often related to depression is exposure to threatening life events. On the other hand, from a genetic point of view, the serotonin transporter gene, with a crucial role in communication between neurons, could predispose a person to depression. [click link for full article]
Depression and obesity - DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results For DOV 21,947
Friday, August 10th, 2007DOV Pharmaceutical, Inc. (”DOV” or the “Company”) (Pink Sheets: DOVP.PK) today announced Phase Ib results for DOV 21,947, its lead triple reuptake inhibitor (”TRIP”) for the treatment of depression and obesity. Preliminary analysis of the study results indicates DOV 21,947 was safe and well-tolerated at the doses examined and produced a significant decline in plasma triglyceride levels. [click link for full article]
Approval Of Wyeth’s Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say
Tuesday, August 7th, 2007FDA’s request for more data on Wyeth’s experimental drug Pristiq as a nonhormonal treatment for hot flashes and other menopausal symptoms should not delay its approval as a depression treatment, company officials said Tuesday, the [click link for full article]
Mental Health 101 - American Psychiatric Association
Sunday, August 5th, 2007Across the country, students are preparing to start or return to college. This is an exciting time, though for some it’s overwhelming and stressful. Depression, substance use and eating disorders are increasingly common mental health issues on college campuses. According to a recent survey1, the rate of students reporting ever being diagnosed with depression has increased 56 percent in the last six years, from 10 percent in spring 2000 to 16 percent in spring 2005. [click link for full article]
Next Entries »